Mrs Ulrike Theidel

Xcenda GmbH, Hannover (Germany)

Follow

Contributor content

Budget impact of iv iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany

Presentation

Budget impact of iv iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany

ESC 365 is supported by

novartis

Explore sponsored resources